Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gynecologic Oncology
•
Medical Oncology
•
Supportive Care
•
General Internal Medicine
•
Immune-related adverse events
•
Rheumatology
•
Neurology
•
Endocrinology
•
General Endocrinology
How do you manage suspected hypophysitis/hypopituitarism as an immune-related adverse event?
What lab tests/imaging do you obtain and how do you initially treat?
Related Questions
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
Should GLP-1 agonists be held during chemotherapy?
What infections should we rule out in patients who develop diarrhea on immunotherapy?
Would you favor oral bisphosphonates over intravenous formulations for patients with hormone sensitive prostate cancer and androgen deprivation therapy (ADT) related osteopenia?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
How do you approach restarting immunotherapy in a patient with metastatic melanoma who previously developed immune-mediated hepatitis (Grade 3), with liver enzymes now back to baseline levels?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
When screening for malignancy, do you order CT with contrast (or) both with and without contrast?